Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 181

1.

Inhalational therapy for pulmonary arterial hypertension: current status and future prospects.

Gupta V, Ahsan F.

Crit Rev Ther Drug Carrier Syst. 2010;27(4):313-70. Review.

PMID:
20932241
2.

Clinical value of prostacyclin and its analogs in the management of pulmonary arterial hypertension.

Dandel M, Hetzer R.

Curr Vasc Pharmacol. 2003 Jun;1(2):171-81. Review.

PMID:
15320842
3.

Iloprost inhalation solution for the treatment of pulmonary arterial hypertension.

Hsu HH, Rubin LJ.

Expert Opin Pharmacother. 2005 Sep;6(11):1921-30. Review.

PMID:
16144511
4.

Prostanoid therapy for pulmonary arterial hypertension.

Badesch DB, McLaughlin VV, Delcroix M, Vizza CD, Olschewski H, Sitbon O, Barst RJ.

J Am Coll Cardiol. 2004 Jun 16;43(12 Suppl S):56S-61S. Review.

5.

Prostacyclin therapy for pulmonary arterial hypertension: new directions.

Gomberg-Maitland M, Preston IR.

Semin Respir Crit Care Med. 2005 Aug;26(4):394-401. Review.

PMID:
16121316
6.

The potential for inhaled treprostinil in the treatment of pulmonary arterial hypertension.

Gessler T, Seeger W, Schmehl T.

Ther Adv Respir Dis. 2011 Jun;5(3):195-206. doi: 10.1177/1753465810397693. Epub 2011 Feb 7. Review.

PMID:
21300738
7.

Cost effectiveness of prostacyclins in pulmonary arterial hypertension.

Roman A, Barberà JA, Escribano P, Sala ML, Febrer L, Oyagüez I, Sabater E, Casado MA.

Appl Health Econ Health Policy. 2012 May 1;10(3):175-88. doi: 10.2165/11630780-000000000-00000. Review.

PMID:
22452448
8.

[Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to pulmonary fibrosis].

Olschewski H, Ghofrani HA, Walmrath D, Schermuly R, Temmesfeld-Wollbrück B, Grimminger F, Seeger W.

Pneumologie. 2000 Mar;54(3):133-42. German.

PMID:
10783653
9.

Treatments and strategies to optimize the comprehensive management of patients with pulmonary arterial hypertension.

Gildea TR, Arroliga AC, Minai OA.

Cleve Clin J Med. 2003 Apr;70 Suppl 1:S18-27. Review.

PMID:
12716139
10.

Inhaled iloprost in pulmonary arterial hypertension.

Baker SE, Hockman RH.

Ann Pharmacother. 2005 Jul-Aug;39(7-8):1265-74. Review.

PMID:
15976392
11.

Prostanoids for pulmonary arterial hypertension.

Galiè N, Manes A, Branzi A.

Am J Respir Med. 2003;2(2):123-37. Review.

PMID:
14720012
12.

Favorable effects of inhaled treprostinil in severe pulmonary hypertension: results from randomized controlled pilot studies.

Voswinckel R, Enke B, Reichenberger F, Kohstall M, Kreckel A, Krick S, Gall H, Gessler T, Schmehl T, Ghofrani HA, Schermuly RT, Grimminger F, Rubin LJ, Seeger W, Olschewski H.

J Am Coll Cardiol. 2006 Oct 17;48(8):1672-81. Epub 2006 Sep 26.

13.

Treprostinil for the treatment of pulmonary arterial hypertension.

Torres F, Rubin LJ.

Expert Rev Cardiovasc Ther. 2013 Jan;11(1):13-25. doi: 10.1586/erc.12.160. Review.

PMID:
23259441
14.
15.

Inhaled treprostinil: a therapeutic review.

Channick RN, Voswinckel R, Rubin LJ.

Drug Des Devel Ther. 2012;6:19-28. doi: 10.2147/DDDT.S19281. Epub 2012 Jan 24. Review.

16.

Antiremodeling effects of iloprost and the dual-selective phosphodiesterase 3/4 inhibitor tolafentrine in chronic experimental pulmonary hypertension.

Schermuly RT, Kreisselmeier KP, Ghofrani HA, Samidurai A, Pullamsetti S, Weissmann N, Schudt C, Ermert L, Seeger W, Grimminger F.

Circ Res. 2004 Apr 30;94(8):1101-8. Epub 2004 Mar 18.

17.

Pharmacotherapeutic management of pulmonary arterial hypertension.

Anderson JR, Nawarskas JJ.

Cardiol Rev. 2010 May-Jun;18(3):148-62. doi: 10.1097/CRD.0b013e3181d4e921. Review.

PMID:
20395700
18.

Current pharmacological treatment of pulmonary arterial hypertension.

Steiropoulos P, Trakada G, Bouros D.

Curr Clin Pharmacol. 2008 Jan;3(1):11-9. Review.

PMID:
18690874
19.

Safety and efficacy of transition from subcutaneous treprostinil to oral sildenafil in patients with pulmonary arterial hypertension.

Keogh AM, Jabbour A, Weintraub R, Brown K, Hayward CS, Macdonald PS.

J Heart Lung Transplant. 2007 Nov;26(11):1079-83. Epub 2007 Oct 24.

PMID:
18022071
20.

Treatment of pulmonary arterial hypertension in pregnancy.

Huang S, DeSantis ER.

Am J Health Syst Pharm. 2007 Sep 15;64(18):1922-6.

PMID:
17823103

Supplemental Content

Support Center